1. Home
  2. Labeler Index
  3. Regeneron Pharmaceuticals, Inc.
  4. 61755-018
  5. NDC Package Code: 61755-018-01 Inmazeb

NDC Package 61755-018-01 Inmazeb

Atoltivimab,Maftivimab,And Odesivimab-ebgn Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61755-018-01
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00)
Product Code:
61755-018
Proprietary Name:
Inmazeb
Non-Proprietary Name:
Atoltivimab, Maftivimab, And Odesivimab-ebgn
Substance Name:
Atoltivimab; Maftivimab; Odesivimab
Usage Information:
INMAZEB is indicated for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection [see Dosage and Administration (2.2), and Clinical Studies (14)].
11-Digit NDC Billing Format:
61755001801
NDC to RxNorm Crosswalk:
  • RxCUI: 2461536 - atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG in 14.5 ML Injection
  • RxCUI: 2461536 - 14.5 ML atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML Injection
  • RxCUI: 2461536 - atoltivimab-ebgn 16.67 MG/ML / maftivimab-ebgn 16.67 MG/ML / odesivimab-ebgn 16.67 MG/ML per 14.5 ML Injection
  • RxCUI: 2461536 - atoltivimab-ebgn 241.7 MG / maftivimab-ebgn 241.7 MG / odesivimab-ebgn 241.7 MG per 14.5 ML Injection
  • RxCUI: 2461536 - atoltivimab-maftivimab-odesivimab-ebgn 241.7 MG / 241.7 MG / 241.7 MG per 14.5 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Regeneron Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • ATOLTIVIMAB 241.7 mg/14.5mL
  • MAFTIVIMAB 241.7 mg/14.5mL
  • ODESIVIMAB 241.7 mg/14.5mL
    • Sample Package:
    No
    FDA Application Number:
    BLA761169
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    10-14-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61755-018-01?

    The NDC Packaged Code 61755-018-01 is assigned to a package of 1 vial, single-dose in 1 carton / 14.5 ml in 1 vial, single-dose (61755-018-00) of Inmazeb, a human prescription drug labeled by Regeneron Pharmaceuticals, Inc.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 61755-018 included in the NDC Directory?

    Yes, Inmazeb with product code 61755-018 is active and included in the NDC Directory. The product was first marketed by Regeneron Pharmaceuticals, Inc. on October 14, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 61755-018-01?

    The 11-digit format is 61755001801. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-261755-018-015-4-261755-0018-01